Science
Flexible and protected – EurekAlert
In the fight against the coronavirus, SARS-CoV-2 researchers from multiple research institutions in Germany have combined their resources to study the spike protein on the surface of the virus. With its spikes, the virus binds to human cells and infects them.…
At the start of a COVID-19 infection, the coronavirus SARS-CoV-2 docks onto human cells using the spike-like proteins on its surface. The spike protein is at the centre of vaccine development because it triggers an immune response in humans. A group of German scientists, including members of the European Molecular Biology Laboratory (EMBL) in Heidelberg, the Max Planck Institute of Biophysics, the Paul-Ehrlich-Institut, and Goethe University Frankfurt have focused on the surface structure of the…
-
Business21 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News19 hours agoBrisbane news live: Broken-down train causes peak-hour delays